Trial intelligence / Profile preview

PK and Response to Acyclovir for Genital Herpes in African Women

NCT02053142Completed

Sponsor
University of North Carolina at Chapel Hill
Start
Jan 2009
Primary completion
Dec 2009
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

Randomised, double-blind trial of aciclovir in genital herpes (3 arms), sponsored by University of North Carolina at Chapel Hill. Primary endpoint: Area Under the Curve at 8 hours. Started Jan 2009; status: completed.

02

Drugs

aciclovir
03

Conditions

genital herpes

Beyond the preview

Go deeper on NCT02053142.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02053142.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call